1h Free Analyst Time
Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2019Speak directly to the analyst to clarify any post sales queries you may have.
Summary
The Medical Devices sector report, “Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2019“ provides an overview of Coronary Artery Bypass Graft Surgery currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Artery Bypass Graft Surgery pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by the team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Coronary Artery Bypass Graft Surgery under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Coronary Artery Bypass Graft Surgery and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Coronary Artery Bypass Graft Surgery under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Introduction
2 Products under Development
3 Coronary Artery Bypass Graft Surgery - Pipeline Products under Development by Companies
4 Coronary Artery Bypass Graft Surgery Companies and Product Overview
5 Coronary Artery Bypass Graft Surgery- Recent Developments
6 Appendix
List of Tables
List of Figures
Companies Mentioned
A selection of companies mentioned in this report includes:
- AdvanSource Biomaterials Corporation
- Axcelon Biopolymers Corp.
- CardioPolymers Inc
- Cardious Inc
- Centre Hospitalier Universitaire de Nice
- Coromedic Ltd.
- Elana bv
- Graft-Loc Inc.
- H. Lee Moffitt Cancer Center & Research Institute Inc
- Hancock Jaffe Laboratories Inc
- iiTech BV
- McGill University
- Medical 21 Inc
- Myocardial Assist Systems and Technology LLC
- Neograft Technologies Inc
- PetVivo Holdings Inc
- RegenMedTX LLC
- Rox Medical Inc
- SeamVad Ltd.
- Surg Solutions SL
- Synovis Micro Companies Alliance Inc
- Thoratec Corp
- Tissue Regeneration Technologies LLC
- University College London
- University Hospital Basel
- University of Arizona
- University of California Los Angeles
- University of Utah
